Associate Director, Clinical Operations
PTC Therapeutics, Inc.
Summary
The Associate Director, Clinical Operations provides the scientific and operational expertise required to lead the execution of the complete life cycle of clinical trials in accordance with appropriate regulatory requirements for one or more indications within or across therapeutic areas. The incumbent works as an integrated member of the clinical team to manage clinical trial(s) from study design through close out. May manage direct report(s). Works cross-functionally with internal departments and external resources on Clinical Operations related issues. Supports adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs).
Job description
Essential Functions
- Performs as an integrated member of the clinical team to lead, direct and contribute to, the planning, execution, and reporting of clinical trials, including estimation of clinical project timelines, protocol writing, Case Report Form (CRF) design, site selection, study drug forecasting, site and Clinical Research Organization (CRO) management, data review, and study reporting; recommends monitoring, safety, eligibility, enrollment, and data consistency strategies.
- Interacts with external and internal project team members to assist in the development of clinical strategies, trial design, study plans, and project deliverables; meets with investigators and PTC scientific and clinical staff to obtain direction and feedback.
- Assists in the evaluation of scientific literature and investigator advice regarding current clinical practice as a component of clinical strategy and protocol development; writes, reviews and/or edits study protocols, protocol amendments, study manuals, informed consent forms, and related documents.
- Prepares investigational site lists and participates in the review and approval of investigational sites; negotiates contracts and budgets with sites and vendors and presents to the project team for approval; plans, coordinates, and conducts investigator meetings including presentations at the meetings; responds to questions from sites and trial monitors regarding trial conduct.
- Manages clinical study timelines using the appropriate project management tools; develops budgets and manages expenditures for clinical trial program, including those for investigational sites and vendors; presents project progress reports through accurate, succinct summaries of clinical study work at internal team meetings and investigator meetings.
- Facilitates regulatory submissions and communications by working with appropriate team members during the submission process; writes assigned portions of reports for submission to regulatory agencies, institutional review boards, scientific journals, and conferences.
- Provides on-going review of clinical trial data to ensure timely, consistent, and accurate data; assists in the interpretation of clinical data in preparation for clinical study reports and regulatory submissions.
- Manages, coaches and mentors direct reports.
Knowledge/Skills/Abilities Required
- Bachelor's degree in a scientific discipline and a minimum of 7 years progressively responsible US and/or global experience in clinical research in a pharmaceutical, biotechnology, CRO, university medical center or related environment.
- Comprehensive working knowledge of the drug developmental process.
- Working knowledge of clinical trial design, conduct, data acquisition, and reporting.
- Ability to recognize safety and efficacy trends of clinical data.
- Hands-on experience supporting and understanding Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and International Conference on Harmonisation (ICH) guidelines.
- Ability to influence without direct authority.
- Proficiency with Microsoft Word and Excel.
- Excellent verbal and written communication and skills.
- Ability to work independently and collaboratively, as required, in a fast-paced, matrixed, team environment consisting of internal and external team members.
- Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines.
- Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects.
Preferred Qualifications
- Prior involvement in Investigational New Drug applications (INDs) and New Drug Applications (NDAs) submissions.
- Previous experience as a field monitor.
- Medical writing experience or training.
- Proficiency with Microsoft Project and Powerpoint.
- People and project management experience.
Travel requirements: Up to 20%.
Requirements
- Bachelor's degree in a scientific discipline
- Minimum of 7 years progressively responsible US and/or global experience in clinical research in a pharmaceutical, biotechnology, CRO, university medical center or related environment
- Comprehensive working knowledge of the drug developmental process
- Working knowledge of clinical trial design, conduct, data acquisition, and reporting
- Ability to recognize safety and efficacy trends of clinical data
- Hands-on experience supporting and understanding Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and International Conference on Harmonisation (ICH) guidelines
- Ability to influence without direct authority
- Proficiency with Microsoft Word and Excel
- Excellent verbal and written communication and skills
- Ability to work independently and collaboratively in a fast-paced, matrixed, team environment
- Analytical thinker with excellent problem-solving skills and ability to adapt to changing priorities and deadlines
- Excellent planning, organization and time management skills including ability to support and prioritize multiple projects
Benefits
- Medical insurance
- Dental insurance
- Vision insurance
- Retirement savings plans
- Short-term incentives
- Long-term incentives
Company overview
PTC Therapeutics, Inc. is a patient-centered biopharmaceutical company founded in 1998 and headquartered in Warren, New Jersey. The company specializes in discovering, developing, and commercializing innovative medicines for children and adults living with rare and serious diseases. PTC focuses on orally administered small molecule drugs and gene therapies that regulate gene expression by targeting post-transcriptional control mechanisms. The company's therapeutic areas include orphan and ultra-orphan disorders, oncology, and anti-infectives, with a particular emphasis on genetic disorders affecting metabolism and neurology. PTC's commercialized products include treatments for Duchenne muscular dystrophy, aromatic L-amino acid decarboxylase deficiency, spinal muscular atrophy, and other rare conditions. The company operates globally with a dedicated team of approximately 939 employees and maintains a robust pipeline of investigational therapies. PTC is publicly traded on NASDAQ under the symbol PTCT and has established itself as a leader in rare disease therapeutics through its commitment to scientific innovation and patient-focused approach.